These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 50879

  • 1. Tumor immunoprophylaxis in mice using glutaraldehyde-treated syngeneic tumor cells.
    Frost P, Sanderson CJ.
    Cancer Res; 1975 Oct; 35(10):2646-50. PubMed ID: 50879
    [Abstract] [Full Text] [Related]

  • 2. Induction of resistance to ascites tumor in mice with MFS-180 cells treated with glutaraldehyde, lipopolysaccharide, and concanavalin A.
    Nerkar DP, Chander R, Bandekar JR, Lewis NF.
    Cancer Res; 1981 Jul; 41(7):2922-4. PubMed ID: 6788363
    [Abstract] [Full Text] [Related]

  • 3. The induction of tumour immunity in mice using glutaraldehyde-treated tumor cells.
    Sanderson CJ, Frost P.
    Nature; 1974 Apr 19; 248(5450):690-1. PubMed ID: 4208483
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
    Hines DL.
    Cancer Res; 1986 Oct 19; 46(10):4921-6. PubMed ID: 3489516
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of TSTA and species-specific cell membrane antigens of tumor cells to glutaraldehyde treatment.
    Kluchareva TE, Matveeva VA, Deichman GI.
    Neoplasma; 1978 Oct 19; 25(3):273-8. PubMed ID: 98720
    [Abstract] [Full Text] [Related]

  • 6. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
    DeLustro F, Haskill JS.
    J Natl Cancer Inst; 1980 Jan 19; 64(1):125-30. PubMed ID: 6928037
    [Abstract] [Full Text] [Related]

  • 7. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1977 Apr 19; 37(4):964-8. PubMed ID: 403001
    [Abstract] [Full Text] [Related]

  • 8. Immunological analysis of A strain mice bearing the A-10 mammary adenocarcinoma.
    Tax A, Manson LA.
    Cancer Res; 1979 May 19; 39(5):1739-47. PubMed ID: 85488
    [Abstract] [Full Text] [Related]

  • 9. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells.
    Shimizu J, Suda T, Yoshioka T, Kosugi A, Fujiwara H, Hamaoka T.
    J Immunol; 1989 Feb 01; 142(3):1053-9. PubMed ID: 2464022
    [Abstract] [Full Text] [Related]

  • 10. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
    Flood PM, Schreiber H, Ron Y.
    J Immunol; 1987 May 15; 138(10):3573-9. PubMed ID: 3571978
    [Abstract] [Full Text] [Related]

  • 11. Induction of antitumor immunity by tumor cells treated with abrin.
    Shionoya H, Arai H, Koyanagi N, Ohtake S, Kobayashi H, Kodama T, Kato H, Tung TC, Lin JY.
    Cancer Res; 1982 Jul 15; 42(7):2872-6. PubMed ID: 7083176
    [Abstract] [Full Text] [Related]

  • 12. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
    Hostetler LW, Romerdahl CA, Kripke ML.
    Cancer Res; 1989 Mar 01; 49(5):1207-13. PubMed ID: 2465081
    [Abstract] [Full Text] [Related]

  • 13. Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection.
    Pellis NR, Kahan BD.
    J Immunol; 1975 Dec 01; 115(6):1717-22. PubMed ID: 52676
    [Abstract] [Full Text] [Related]

  • 14. Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.
    Ben-Efraim S, Ophir R, Relyveld EH.
    Br J Cancer; 1981 Apr 01; 43(4):554-7. PubMed ID: 6786316
    [No Abstract] [Full Text] [Related]

  • 15. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization.
    McCune CS, O'Donnell RW, Horan PK, Budd HS, Spennacchio JL, Chuang C, Henshaw EC.
    J Natl Cancer Inst; 1982 Sep 01; 69(3):647-52. PubMed ID: 6955557
    [Abstract] [Full Text] [Related]

  • 16. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
    Economou GC, Takelchi N, Boone CW.
    Cancer Res; 1977 Jan 01; 37(1):37-41. PubMed ID: 63329
    [Abstract] [Full Text] [Related]

  • 17. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E, Aruga A, Arca MJ, Lee WM, Yang NS, Smith JW, Chang AE.
    Cancer Gene Ther; 1997 Jan 01; 4(3):157-66. PubMed ID: 9171934
    [Abstract] [Full Text] [Related]

  • 18. The development of cellular immunity to tumor cells.
    Cerilli J, Smith MC.
    Surg Gynecol Obstet; 1972 May 01; 134(5):739-45. PubMed ID: 5064081
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM, Sigel MM, Charyulu VL.
    J Natl Cancer Inst; 1981 Jan 01; 66(1):191-6. PubMed ID: 6256573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.